Skip to main content
OpenTrials
Completed

NCT Number: NCT03871010

Midline Programme - Vascular Nursing Team

Integration of the Vascular Nursing Team of the Department of Haematooncology, University Hospital Ostrava for the needs of all clinical departments of the hospital. Assessment of local signs of inflammation in patients of the Department of Haematooncology and other clinical departments of the University Hospital Ostrava.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Inflammation Infections Local; Infection Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Ostrava

Ostrava-Poruba, Czech Republic, 708 52, Czechia

About this study

The study subjects were indicated by a physician for Midline catheter insertion.

Prior to insertion of the catheter, the study subjects were fully informed and signed the informed consent with participation in the study.

Local signs of inflammation were recorded in the study subjects, together with basic demographic characteristics (age, sex, diagnosis), and complications during catheter insertion, the number of days when the Midline catheter was inserted, number of changes of the dressings, presence of neutropenia in the study subjects and the score of local inflammation according to Madonna.

  • Degree 0- no pain or reaction in the surrounding
  • Degree 1 - pain only, no reaction in the surrounding
  • Degree 2 - pain and reddening
  • Degree 3 - pain, reddening, swelling or painful stripe along the vein
  • Degree 4 - puss, swelling, reddening and painful stripe along the vein The investigators also observed on which day the first signs of infection appeared.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • insertion of Midline catheter by nurses from the Vascular Nursing Team
  • age over 18 years

Exclusion criteria

  • inability to insert the Midline catheter

Treatment and study plan

Midline Catheter

Device

Midline catheter is used for administration of intravenous therapy, and is inserted in a larger vein.

Primary outcomes

  1. Local signs of infection

    Time frame: 3 days at minimum

    Local signs of infection were recorded, using the scoring system according to Madonna - see detailed description.

Sponsors and collaborators

Lead sponsor

University Hospital Ostrava

Other

Registry information

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Mar 12, 2019
Registry last updated
Oct 6, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.